SCHEMBL24553685

SCHEMBL24553685

N#CCc1nc2cc(Cl)cc(Cl)c2[nH]1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ AR P10275 1/20 0.33
▸ GAA P10253 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ GRIN2D O15399 1/20 0.32
▸ GRIN3B O60391 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2A Q12879 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ GRIN2C Q14957 1/20 0.32
▸ GRIN3A Q8TCU5 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PSMB8 P28062 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ EGFR P00533 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29732979 1.00 CSNK2A1 (0.34) CSNK2A1CYP1A2ARGAAHTT
SCHEMBL11583058 0.84 GAA (0.34) CSNK2A1ARGAAHTT
SCHEMBL10284441 0.78 GAA (0.54) CYP1A2GAAHTTKDM4EGRIN2D
SCHEMBL11585640 0.77 MAPT (0.39) CYP1A2KDM4EALDH1A1PSMB8EGFR
SCHEMBL15844358 0.75 RAD52 (0.43) CYP1A2GAAHTTKDM4EGRIN2D
SCHEMBL11339364 0.74 TDP1 (0.47) GAAHTTKDM4EALDH1A1PSMB8
SCHEMBL6311477 0.73 GAA (0.62) CSNK2A1ARGAAHTTGRIN2D
SCHEMBL19399634 0.73 PRKAG1 (0.42) GAAKDM4EGRIN2DGRIN3BALDH1A1
SCHEMBL7045022 0.71 CYP1A2 (0.40) CYP1A2ARGAAHTTKDM4E
SCHEMBL11749723 0.71 TSHR (0.36) CYP1A2GAAKDM4EGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4736860-A2 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF Shenzhen Keye Life Technologies, Co., Ltd. (CN) 2026-05-06 — — EP disclosed
CN-114634491-B Polycyclic compound for inhibiting RNA helicase DHX33 成都开悦生命科技有限公司 2024-03-19 — — CN disclosed
US-20230146233-A1 A CLASS OF POLYCYCLIC COMPOUNDS INHIBITING RNA HELICASE DHX33 AND THE APPLICATION THEREOF SHENZHEN KEYE LIFE TECHNOLOGIES, CO., LTD (CN) 2023-05-11 — — US disclosed
US-20230146233-A1 A CLASS OF POLYCYCLIC COMPOUNDS INHIBITING RNA HELICASE DHX33 AND THE APPLICATION THEREOF SHENZHEN KEYE LIFE TECHNOLOGIES, CO., LTD (CN) 2023-05-11 — — US disclosed
EP-4089089-A1 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF Shenzhen Keye Life Technologies, Co., Ltd. (CN) 2022-11-16 — — EP disclosed
WO-2022127199-A1 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF 深圳开悦生命科技有限公司 2022-06-23 — — WO disclosed
WO-2022127199-A1 POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF 深圳开悦生命科技有限公司 2022-06-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146233-A1 A CLASS OF POLYCYCLIC COMPOUNDS INHIBITING RNA HELICASE DHX33 AND THE APPLICATION THEREOF DHX36, DDX21, DDX3X CSNK2A1 2806/4885CYP1A2 4217/4885AR 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback